{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T09:34:09Z","timestamp":1780479249664,"version":"3.54.1"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1097\/adm.0b013e31826b767f","type":"journal-article","created":{"date-parts":[[2012,9,15]],"date-time":"2012-09-15T11:37:45Z","timestamp":1347709065000},"page":"265-273","source":"Crossref","is-referenced-by-count":13,"title":["Safety of Atomoxetine in Combination With Intravenous Cocaine in Cocaine-Experienced Participants"],"prefix":"10.1097","volume":"6","author":[{"given":"Louis","family":"Cantilena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie C.","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shou-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Elkashef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210126","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/00952990701407694","article-title":"Acute cocaine responses following cocaethylene infusion.","volume":"33","author":"Baker","year":"2007","journal-title":"Am J Drug Alcohol Abuse"},{"key":"R2-5-20210126","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.biopsych.2006.04.022","article-title":"Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function.","volume":"60","author":"Berridge","year":"2006","journal-title":"Biol Psychiatry"},{"key":"R3-5-20210126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2008.06.004","article-title":"Impaired object recognition following prolonged withdrawal from extended-access cocaine self-administration.","volume":"155","author":"Briand","year":"2008","journal-title":"Neuroscience"},{"key":"R4-5-20210126","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0893-133X(02)00346-9","article-title":"Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficithyperactivity disorder.","volume":"27","author":"Bymaster","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"R5-5-20210126","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0010-440X(93)90050-E","article-title":"History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers.","volume":"34","author":"Carroll","year":"1993","journal-title":"Compr Psychiatry"},{"key":"R6-5-20210126","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.biopsych.2007.03.003","article-title":"Atomoxetine improved response inhibition in adults with attention deficithyperactivity disorder.","volume":"62","author":"Chamberlain","year":"2007","journal-title":"Biol Psychiatry"},{"key":"R8-5-20210126","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00213-010-2087-1","article-title":"Peripheral biomarkers of cognitive response to dopamine receptor agonist treatment.","volume":"214","author":"Ersche","year":"2011","journal-title":"Psychopharmacology"},{"key":"R9-5-20210126","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0166-4328(01)00379-5","article-title":"Effects of histamine H3 receptor ligands GT-2331 and ciprofloxacin in a repeated acquisition avoidance response in the spontaneously hypertensive rat pup.","volume":"131","author":"Fox","year":"2002","journal-title":"Behav Brain Res"},{"key":"R10-5-20210126","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.biopsycho.2006.11.003","article-title":"Error-processing deficits in patients with cocaine dependence.","volume":"75","author":"Franken","year":"2007","journal-title":"Biol Psychol"},{"key":"R11-5-20210126","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1017\/S1092852900009330","article-title":"Potential noradrenergic targets for cognitive enhancement in schizophrenia.","volume":"9","author":"Friedman","year":"2004","journal-title":"CNS Spectr"},{"key":"R12-5-20210126","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1345\/aph.1G582","article-title":"Atomoxetine versus stimulants for treatment of attention deficithyperactivity disorder.","volume":"40","author":"Gibson","year":"2006","journal-title":"Ann Pharmacother"},{"key":"R13-5-20210126","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.psychres.2007.11.019","article-title":"Attention deficits in cocaine dependent patients: converging behavioral and electrophysiological evidence.","volume":"160","author":"Gooding","year":"2008","journal-title":"Psychiatry Res"},{"key":"R14-5-20210126","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0376-8716(02)00053-4","article-title":"Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users.","volume":"67","author":"Heil","year":"2002","journal-title":"Drug Alcohol Depend"},{"key":"R15-5-20210126","first-page":"65","article-title":"A simple sequentially rejective multiple test procedure.","volume":"6","author":"Holm","year":"1979","journal-title":"Scand J Stat"},{"key":"R16-5-20210126","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.drugalcdep.2008.01.008","article-title":"Abuse liability assessment of atomoxetine in a drug-abusing population.","volume":"95","author":"Jasinski","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"R17-5-20210126","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0376-8716(98)00049-0","article-title":"Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment.","volume":"52","author":"Levin","year":"1998","journal-title":"Drug Alcohol Depend"},{"key":"R18-5-20210126","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal analysis using generalized linear models.","volume":"73","author":"Liang","year":"1986","journal-title":"Biometrika"},{"key":"R19-5-20210126","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1742-7843.2008.00230.x","article-title":"Atomoxetine increases histamine release and improves learning deficits in an animal model of attention-deficit hyperactivity disorder: the spontaneously hypertensive rat.","volume":"102","author":"Liu","year":"2008","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"R20-5-20210126","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3928\/0048-5713-19981001-08","article-title":"Craving and withdrawal symptoms for various drugs of abuse.","volume":"28","author":"Mezinskis","year":"1998","journal-title":"Psychiatr Ann"},{"key":"R21-5-20210126","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.4088\/JCP.v68n1222d","article-title":"Treatment of cognitive deficits in schizophrenia with atomoxetine: a case report.","volume":"68","author":"Rao","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"R22-5-20210126","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1089\/neu.2007.0389","article-title":"Post-injury atomoxetine treatment improves cognition following experimental traumatic brain injury.","volume":"25","author":"Reid","year":"2008","journal-title":"J Neurotrauma"},{"key":"R23-5-20210126","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.drugalcdep.2008.08.009","article-title":"Cocaine effects during d-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy.","volume":"99","author":"Rush","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"R24-5-20210126","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.drugalcdep.2007.07.005","article-title":"Safety, tolerability and subject-rated effects of acute intranasal cocaine administration during atomoxetine maintenance.","volume":"92","author":"Stoops","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"R25-5-20210126","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.neuropharm.2005.11.022","article-title":"Effect of the attention deficithyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat.","volume":"50","author":"Swanson","year":"2006","journal-title":"Neuropharmacology"}],"container-title":["Journal of Addiction Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/01271255-201212000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T05:34:16Z","timestamp":1618032856000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01271255-201212000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/adm.0b013e31826b767f","relation":{},"ISSN":["1932-0620"],"issn-type":[{"value":"1932-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}